Martino Pedrani

9PUBLICATIONS
45CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cellular immunologyPredictive and prognostic markersLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 29, 2026
DLL3-Targeted Strategies in Advanced Prostate Cancer: Current Evidence and Future Perspectives.

|May 28, 2026
EMETPRO: a multicentric, international, retrospective analysis evaluating patients with metastatic hormone-sensitive prostate cancer with early progression.

|Apr 28, 2026
Hot flushes during ADT for prostate cancer - a clinical rationale for a neurokinin 3 receptor antagonist.

|Jan 10, 2026
ChronoimmunoTOX: A Single-Institution Retrospective Study on How the Time of Administration Impacts Immune Checkpoint Inhibitor Efficacy and Toxicity in Melanoma.

Alessandro Nepote, Gilles Burghgraeve, Martino Pedrani

|Dec 11, 2025
Predicting Toxicities and Survival Outcomes in De Novo Metastatic Hormone-Sensitive Prostate Cancer Using Clinical Features, Routine Blood Tests and Their Early Variations.

Giuseppe Salfi, Martino Pedrani, Amos Colombo

|Jun 13, 2025
Integrating Aggressive-Variant Prostate Cancer-Associated Tumor Suppressor Gene Status with Clinical Variables to Refine Prognosis and Predict Androgen Receptor Pathway Inhibitor Response in Metastatic Hormone-Sensitive Setting.

Martino Pedrani, Giuseppe Salfi, Sara Merler

Pageof 2

Frequent Collaborators

5 joint publications

Ricardo Pereira Mestre

5 joint publications

Giuseppe Salfi

4 joint publications

Ursula Vogl

3 joint publications

Silke Gillessen